Literature DB >> 9275083

Adrenal control of erectile function and nitric oxide synthase in the rat penis.

D F Penson1, C Ng, J Rajfer, N F Gonzalez-Cadavid.   

Abstract

Penile erection is a nitric oxide (NO)-mediated process that has been shown to be androgen dependent in rats. Castration reduces the activity of the penile enzyme involved in NO synthesis, nitric oxide synthase (NOS). To determine whether adrenal androgens and/or corticosteroids contribute to this control, the following groups of Fischer 344 adult male rats (n = 5-7) were studied: 1) intact, 2) castrated, 3) adrenalectomized alone, 4) castrated/adrenalectomized, 5) castrated/adrenalectomized with aldosterone (1.25 mg/kg, s.c.) and hydrocortisone (12 mg/kg, s.c.), 6) castrated/adrenalectomized with dihydrotestosterone (1.2-cm SILASTIC-brand tubing pellet; Dow Corning, Midland, MI), 7) castrated/adrenalectomized with dehydroepiandrosterone (2-cm tubing), 8) castrated/adrenalectomized with aldosterone (1.25 mg/kg, s.c.), and 9) castrated/adrenalectomized with hydrocortisone (12 mg/kg, s.c.). After 1 week, EFS was applied, and the maximal intracavernosal pressure (MIP) and mean arterial pressure (MAP) were recorded. The MIP/MAP ratio in the adrenalectomized group (0.37) was reduced to values found in the castrated group (0.40). The values in both groups were significantly less than those in intact controls (0.75). The most significant reduction in MIP/MAP was seen in the adrenalectomized/castrated group (0.16). Erectile response in animals submitted to adrenalectomy and castration was restored close to intact values with the administration of hydrocortisone and aldosterone (0.63). Similar results were obtained by the administration of either of the substances alone (0.56 and 0.67, respectively). Penile NOS activity assayed by the L-arginine/citrulline conversion was decreased by 55% in the castrated group compared with that in the intact group, but was not further reduced in the adrenalectomized/castrated or adrenalectomized groups. Penile neuronal NOS protein content, estimated by Western blot, was decreased only in the adrenalectomized/castrated animals (35%), and endothelial NOS content was not affected. These data suggest that the rat adrenal gland contributes to the maintenance of the erectile mechanism and may affect neuronal NOS content in the penis in the rat model. The possibility that hypotension may play a role in the erectile dysfunction observed in adrenalectomized rats cannot be discarded.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9275083     DOI: 10.1210/endo.138.9.5402

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  9 in total

1.  Synergetic effect of testosterone and phophodiesterase-5 inhibitors in hypogonadal men with erectile dysfunction: A systematic review.

Authors:  Naif Alhathal; Ahmed M Elshal; Serge Carrier
Journal:  Can Urol Assoc J       Date:  2012-08       Impact factor: 1.862

Review 2.  Current use of phosphodiesterase inhibitors in urology.

Authors:  Tariq Said Hakky; Lakshay Jain
Journal:  Turk J Urol       Date:  2015-06

3.  Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting.

Authors:  N F Gonzalez-Cadavid; W E Taylor; K Yarasheski; I Sinha-Hikim; K Ma; S Ezzat; R Shen; R Lalani; S Asa; M Mamita; G Nair; S Arver; S Bhasin
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

4.  Is there an inhibitory role of cortisol in the mechanism of male sexual arousal and penile erection?

Authors:  Stefan Uckert; Mark H Fuhlenriede; Armin J Becker; Christian G Stief; Friedemann Scheller; Wolfram H Knapp; Udo Jonas
Journal:  Urol Res       Date:  2003-09-24

5.  Erectile dysfunction in a murine model of sleep apnea.

Authors:  Galia K Soukhova-O'Hare; Zahoor A Shah; Zhenmin Lei; Alexander D Nozdrachev; C Venkateswara Rao; David Gozal
Journal:  Am J Respir Crit Care Med       Date:  2008-06-05       Impact factor: 21.405

6.  Elevated plasma aldosterone is an independent risk factor for erectile dysfunction in men.

Authors:  Fei Wu; Shanhua Mao; Tianfang Yu; Haowen Jiang; Qiang Ding; Gang Xu
Journal:  World J Urol       Date:  2015-11-02       Impact factor: 4.226

Review 7.  The dark side of 5α-reductase inhibitors' therapy: sexual dysfunction, high Gleason grade prostate cancer and depression.

Authors:  Abdulmaged M Traish; Ashwini Mulgaonkar; Nicholas Giordano
Journal:  Korean J Urol       Date:  2014-06-16

8.  The relationship of serum and salivary cortisol levels to male sexual dysfunction as measured by the International Index of Erectile Function.

Authors:  Y Kobori; E Koh; K Sugimoto; K Izumi; K Narimoto; Y Maeda; H Konaka; A Mizokami; T Matsushita; T Iwamoto; M Namiki
Journal:  Int J Impot Res       Date:  2009-05-07       Impact factor: 2.896

Review 9.  Dehydroepiandrosterone and Erectile Function: A Review.

Authors:  Ahmed I El-Sakka
Journal:  World J Mens Health       Date:  2018-05-11       Impact factor: 5.400

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.